You're two or three weeks in. The scale hasn't moved, you don't feel much of anything, and somebody in one of the reta groups just posted that she's adding a milligram next week because nothing's happening. It is a completely reasonable thing to think. If the amount isn't doing anything, the amount must be too small, and the amount is the only lever anybody handed you. The trouble is that the number is the part of this question that matters least.
The question is how often, not how much
The escalation pattern that circulates for retatrutide starts at around 1 to 2 mg once weekly and steps up roughly every four weeks, working toward a maintenance amount most often described as 4, 8 or 12 mg weekly, reached over something like three to four months.
The interval is the part that gets skipped, because every chart leads with the milligrams and buries it. Four weeks per step means somebody moving up every week is running about four times faster than the shape she thinks she's following, and she almost certainly doesn't know it.
Where the four-week step comes from
It isn't ours and it wasn't invented by whoever posted it. The pattern mirrors how the compound itself was dosed when it was studied, and most of the week-by-week charts you'll find in a search are vendor education pages passing that same shape along. That's the thing to know when you're deciding how fast to move, and it's the same standard we hold on every protocol page: the number matters less than where the number came from.
The exact steps vary by source, and that variation is information too. Nobody has run the study that settles it for research-grade material, so what exists is a shape most sources agree on and a lot of disagreement about the details inside it. Our full write-up of the pattern, with the starting amounts and the slower variant, is on the retatrutide guide and protocols page.
If you're two weeks in and feeling nothing
Feeling nothing at week two is what week two is supposed to feel like. The starting amount isn't a small version of a working dose, it's the bottom of a ramp, and its entire job is to let your body meet the compound before the amount gets big enough to do much. Appetite changes usually turn up well before any weight change does, and both of them usually turn up well after the first fortnight.
A ramp and a search for the dose that finally registers are two different activities, and they feel identical from the inside. That's how people end up running the second one by accident.
What moving up fast actually costs
Two things, and only one of them is money.
The first is that digestive side effects with this compound climb with the weekly amount and are most noticeable in the days right after each step up. A faster ramp means arriving at a larger amount with less settling time behind you, so the symptoms pile up instead of clearing between steps.
The second is that you lose the ability to read your own results. If you moved up last week and again this week and something changed, there is no way to tell which step did it, or whether either of them did. Four weeks between steps is what makes each step readable, and that's a better reason to keep the gap than caution alone.
The money is real as well, and it's mostly not about speed. A maintained 8 to 12 mg weekly, run for a year, works out to roughly 415 to 625 mg in total, which is a lot of vials. What that costs depends far more on where you buy than on how fast you climb, so compare the real price per milligram against that total rather than against the price of a single vial, and buy from vendors who publish third-party purity and identity testing.
If you can't eat, that's a different question
There is one signal that isn't about the schedule at all, and it's the sentence the groups repeat more than any other: if you can't eat, the dose is ahead of you. Nausea that's unpleasant is one thing. Nausea that's keeping food and fluid out of you day after day is another, and pushing through it is the wrong instinct for reasons that have nothing to do with toughness. We've written that one up on its own, in when retatrutide side effects mean the dose is too high.
Where to go from here
The retatrutide guide and protocols page has the full escalation pattern, the reconstitution math, and how it compares to tirzepatide if you're still weighing the two. The research notes carry the studies behind it. And our price comparison tool runs the per-milligram math across vetted vendors, which is the number that actually decides what a year of this costs you.
Retatrutide is sold for research and it isn't approved, which means there's no label, no pharmacist, and no large trial in people telling anyone the safe long-term amount. You already know that. You're an adult making an informed call about your own body, and that call is yours to make.